Advanced small cell carcinoma of the ovary in a seventeen-year-old female, successfully treated with surgery and multi-agent chemotherapy

Pediatr Blood Cancer. 2008 May;50(5):1060-2. doi: 10.1002/pbc.21333.

Abstract

Advanced small cell carcinoma of the ovary (FIGO stage III or IV) is a rare and usually lethal tumor seen in adolescents and young women. In pediatric patients with advanced disease, there have been only two case reports of successful therapy, we report a third patient, diagnosed at 17 years of age, with an abdominal mass and metastatic disease to regional and distant lymph nodes, who was successfully treated with surgery and intensive multi-agent chemotherapy. Imatinib, thalidomide, and celecoxib were also administered for up to 24 months following initial chemotherapy. She remains in remission 3 years from diagnosis.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Benzamides
  • Bleomycin / administration & dosage
  • Carcinoma, Small Cell / drug therapy
  • Carcinoma, Small Cell / surgery
  • Carcinoma, Small Cell / therapy*
  • Celecoxib
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Female
  • Humans
  • Imatinib Mesylate
  • Lymph Nodes / pathology
  • Lymphatic Metastasis
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / surgery
  • Ovarian Neoplasms / therapy*
  • Piperazines / administration & dosage
  • Pyrazoles / administration & dosage
  • Pyrimidines / administration & dosage
  • Sulfonamides / administration & dosage
  • Thalidomide / administration & dosage
  • Vinblastine / administration & dosage

Substances

  • Benzamides
  • Piperazines
  • Pyrazoles
  • Pyrimidines
  • Sulfonamides
  • Bleomycin
  • Thalidomide
  • Vinblastine
  • Etoposide
  • Doxorubicin
  • Imatinib Mesylate
  • Cyclophosphamide
  • Celecoxib